Alex Zhavoronkov: Difference between revisions
Tom Morris (talk | contribs) the COI is hardly cut and dried. the link presented on the talk page doesn't seem to make any link with the subject. without substantiation, the accusation of a COI is a possible BLP issue. |
→Career: Advocacy for Aging Research |
||
| Line 32: | Line 32: | ||
==Career== |
==Career== |
||
He is the co-founder and CEO of Insilico Medicine, which according to press releases is a company dedicated to drug discovery for cancer and aging located at the Emerging Technology Centers of the Johns Hopkins University.<ref>[http://www.slideshare.net/genelab1/in-silico-medicine-opens-us-office-prepares-to-launch-drug-discovery-software-for-aging-research-market-bio-inform-informatics-genomeweb GenomeWeb: In Silico Medicine Opens US Office, Prepares to Launch Drug Discovery Software for Aging Research Market by Uduak Grace Thomas, March 28, 2014]</ref><ref>[http://www.streetinsider.com/Press+Releases/InSilico+Medicine+Opens+Office+at+the+Emerging+Technology+Centers+(ETC)+at+Johns+Hopkins+University+Eastern+Campus/9504931.html Street Insider: Insilico Medicine Opens Office at the ETC at Johns Hopkins University Eastern Campus]</ref><ref>[http://www.reuters.com/article/2014/06/04/idUSnGNX7XDF5Y+1dd+GNW20140604 Reuters: The Former Head of the Human Genome Project Joins InSilico Medicine, Inc. in the War on Aging as the Chair of the SAB]</ref> |
He is the co-founder and CEO of Insilico Medicine, which according to press releases is a company dedicated to drug discovery for cancer and aging located at the Emerging Technology Centers of the Johns Hopkins University.<ref>[http://www.slideshare.net/genelab1/in-silico-medicine-opens-us-office-prepares-to-launch-drug-discovery-software-for-aging-research-market-bio-inform-informatics-genomeweb GenomeWeb: In Silico Medicine Opens US Office, Prepares to Launch Drug Discovery Software for Aging Research Market by Uduak Grace Thomas, March 28, 2014]</ref><ref>[http://www.streetinsider.com/Press+Releases/InSilico+Medicine+Opens+Office+at+the+Emerging+Technology+Centers+(ETC)+at+Johns+Hopkins+University+Eastern+Campus/9504931.html Street Insider: Insilico Medicine Opens Office at the ETC at Johns Hopkins University Eastern Campus]</ref><ref>[http://www.reuters.com/article/2014/06/04/idUSnGNX7XDF5Y+1dd+GNW20140604 Reuters: The Former Head of the Human Genome Project Joins InSilico Medicine, Inc. in the War on Aging as the Chair of the SAB]</ref> |
||
==Advocacy for Aging Research== |
|||
Zhavoronkov and collaborators demonstrated that only a small fraction of worldwide government spending on biomedical research is spent on aging research <ref>[http://www.sciencedaily.com/releases/2014/03/140328175217.htm Financial analysis of genetics and epigenetics of aging and longevityv] Science Daily</ref> and developed the productive longevity model of economic growth<ref>{{cite PMID|24217179}}</ref>. Speaking at the International Actuarial Association meeting <ref> [https://www.actuaries.org/EVENTS/Meetings/london/schedule.pdf IAA annual committee meeting, London 2014</ref> he proposed a longevity hedge mechanism for pension funds and insurance companies that would appreciate with longevity increases and help fund companies and research projects focusing on productive longevity increases. |
|||
==Publications== |
==Publications== |
||
Revision as of 12:19, 9 October 2014
Alex Zhavoronkov | |
|---|---|
| Alma mater | Johns Hopkins University (JHU) |
| Scientific career | |
| Fields | aging, regenerative medicine, aging economics |
| Institutions | Biogerontology Research Foundation |
| Website | www.agingportfolio.org/members/Dnamite/ |
Alex Zhavoronkov is a scientist working in biotechnology, regenerative medicine and aging economics. He is the director of the Biogerontology Research Foundation,[1] a UK-based think tank for aging research, and is the director of the International Aging Research Portfolio, open-access repository of biomedical grants".[2][3][4] He is the adjunct professor at the Moscow Institute of Physics and Technology [5] and heads the laboratory of regenerative medicine at the Federal Clinical Research Center for Pediatric Hematology, Oncology and Immunology in Moscow.[6][7]
Education
Zhavoronkov earned two bachelor degrees at Queen's University in computer science and commerce. He has a masters in biotechnology from Johns Hopkins University, and a PhD in physics and mathematics from Moscow State University.[8]
Career
He is the co-founder and CEO of Insilico Medicine, which according to press releases is a company dedicated to drug discovery for cancer and aging located at the Emerging Technology Centers of the Johns Hopkins University.[9][10][11]
Advocacy for Aging Research
Zhavoronkov and collaborators demonstrated that only a small fraction of worldwide government spending on biomedical research is spent on aging research [12] and developed the productive longevity model of economic growth[13]. Speaking at the International Actuarial Association meeting [14] he proposed a longevity hedge mechanism for pension funds and insurance companies that would appreciate with longevity increases and help fund companies and research projects focusing on productive longevity increases.
Publications
Zhavoronkov authored and co-authored over 40 scientific papers.[15] He has contributed articles on trends in aging and longevity for popular press including Huffington Post ,[16] Financial Times Pensions Expert,[17] Next Avenue.[18]
He holds a US patent for methods utilizing brain-computer interfaces for recognizing imagined visual images.[19][20]
Books
“The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy”, Macmillan Publishers, 2013 ISBN 978-0230342200 The book was featured in mainstream and business media [21] including coverage in the Critic section of the Bloomberg Business week,[22] on CBS and online radio stations.[23][24][25]
“Dating A.I.: A guide to falling in love with Artificial Intelligence”, RE/Search, 2012 ISBN 978-1889307350
External links
References
- ^ Charities Commission UK 2013 Trustee Report and Statement of Accounts
- ^ Template:Cite PMID
- ^ Template:Cite PMID
- ^ The International Aging Research Portfolio Launches Longevity Medicine, retrieved 27 Feb 2011.
- ^ MIPT Pharmpersonal: MIPT announces three new adjunct professors 12.12.2013
- ^ Student and Alumni Bibliography: Alex Zhavoronkov, Ph.D, Johns Hopkins University
- ^ "Alex Zhavoronkov". Who’s Who in Gerontology. Human Aging Genomic Resources.
- ^ Biography of Alexander Zhavoronkov Lifeboat.com
- ^ GenomeWeb: In Silico Medicine Opens US Office, Prepares to Launch Drug Discovery Software for Aging Research Market by Uduak Grace Thomas, March 28, 2014
- ^ Street Insider: Insilico Medicine Opens Office at the ETC at Johns Hopkins University Eastern Campus
- ^ Reuters: The Former Head of the Human Genome Project Joins InSilico Medicine, Inc. in the War on Aging as the Chair of the SAB
- ^ Financial analysis of genetics and epigenetics of aging and longevityv Science Daily
- ^ Template:Cite PMID
- ^ [https://www.actuaries.org/EVENTS/Meetings/london/schedule.pdf IAA annual committee meeting, London 2014
- ^ PubMed Bibliography Zhavoronkov's peer-reviewed bibliography
- ^ Huffington Post: 13 Reasons Why We Will Live Longer Than Our Parents
- ^ [Financial Times Pensions Expert: A scheme guide to changing longevity risk
- ^ Next Avenue, Why We Should Look Forward To Living To 120 And Beyond
- ^ Template:Cite PMID
- ^ Patent on BCI for recognizing imagined visual images
- ^ Scheffler, Daniel (July 9, 2013). "The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy (review)".
- ^ Bloomberg Business week, Critic 07.22.2013 pp. 74
- ^ CBS Radio with Dan Raviv in Washington, DC
- ^ Book Tour Radio
- ^ The Evolution of Aging Skeptically Speaking, retrieved June 7, 2013